Skip to main content
27 search results for:

ADA 2022 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 09-23-2022 | EASD 2022 | News | Article

    ADA/EASD hyperglycemia management consensus update strengthens holistic care

    The latest update to the ADA and EASD hyperglycemia management consensus report places a strong emphasis on holistic, person-centered care for type 2 diabetes.

  2. 06-07-2022 | ADA 2022 | News | Article

    ​​​​​​​ADA/KDIGO consensus: ‘Speaking the same language’ on CKD management

    The ADA and KDIGO have produced a consensus statement on treating chronic kidney disease in people with diabetes.

  3. 06-06-2022 | ADA 2022 | News | Article

    Sexual dysfunction common in individuals with prediabetes and type 2 diabetes

    “This suggests that the sexual response in women may be more affected by psychosocial aspects rather than metabolic control or complications of diabetes,” commented Blair. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022 (abstract 86-OR) ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022 (abstract 87-OR

  4. 06-07-2022 | ADA 2022 | News | Article

    ​​​​​​​Artificial intelligence platform shows promise for type 2 diabetes remission

    “The impact of the program on patient satisfaction, quality of life, and total cost of care is substantial and holds significant promise for large populations suffering from metabolic disease globally.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  5. 06-04-2022 | ADA 2022 | News | Article

    ​​​​​​​SURMOUNT-1 places tirzepatide weight loss efficacy within surgical range

    Caplan said that if other mechanisms besides GLP-1 signaling prove to have a powerful effect on fat mass regulation, “then we truly have the ability – as with hypertension, as with diabetes, as with other chronic diseases – to be able to hit it from multiple different mechanisms.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group N Engl J Med 2022; doi:10.1056/NEJMoa2206038 ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  6. 06-04-2022 | ADA 2022 | News | Article

    AWARD-PEDS: Dulaglutide improves glycemic control for youths with type 2 diabetes

    Nevertheless, they observe that dulaglutide’s safety profile in the youths was in line with that in adults and conclude that the medication is “potentially promising” for this younger age group. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group N Engl J Med 2022; doi:10.1056/NEJMoa2204601 ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  7. 06-08-2022 | ADA 2022 | News | Article

    CKD and type 2 diabetes combined conveys greatest vascular risk in people with CVD

    medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  8. 06-08-2022 | ADA 2022 | News | Article

    First-in-class glucokinase activator dorzagliatin could help treat some GK-MODY patients

    She suggested that, while people with GK-MODY who only have one GK mutation may not require this level of treatment, dorzagliatin shows promise for homozygous individuals with GK-MODY and others who develop more severe symptoms. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  9. 06-08-2022 | ADA 2022 | News | Article

    OpenAPS closed-loop algorithm improves glucose control in formal trial

    Time in tight range (3.9–7.8 mmol/L, 70–140 mg/dL) improved by an average of 15.8% between the groups and there was no increase in hypoglycemia. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  10. 06-08-2022 | ADA 2022 | News | Article

    Overnight glycemic variability may impact next day function

    She concluded: “One of those things that we now know is that minimizing variability overnight is probably going to have the best impact on how people feel.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  11. 06-07-2022 | ADA 2022 | News | Article

    Stem cell approach shows promise for unstable type 1 diabetes

    Just one adverse event, of a “mild” rise in liver enzymes post-infusion, was considered related to the treatment. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  12. 06-07-2022 | ADA 2022 | News | Article

    Case series suggests SGLT2 inhibitors could be useful add-on therapy for MODY3

    “We are planning to do a randomized control trial to confirm that SGLT2 inhibitors can lower plasma glucose in these patients,” he explained. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  13. 06-06-2022 | ADA 2022 | News | Article

    Increased time in range using FreeStyle Libre improves multiple diabetes outcomes

    Independent of TIR, there was also a 63% reduction in hospital admissions related to hyperglycemia or diabetic ketoacidosis and an 85% reduction in paramedic callouts in those using the monitor. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  14. 06-06-2022 | ADA 2022 | News | Article

    Annual wellness check may reduce amputation likelihood in high-risk locales

    This was in line with previous research from the team, which found approximately one additional major lower extremity amputation per 1000 people in the Diabetes Belt compared with the surrounding counties. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  15. 06-06-2022 | ADA 2022 | News | Article

    ​​​​​​​Hypoglycemia risk from insulin overdose no worse with icodec than glargine

    In response to a question, Pieber said that participants were monitored for 4 days after the double and triple icodec doses, during which recurrent hypoglycemia episodes were rare and mild, and “easily compensated with oral carbohydrates.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  16. 06-06-2022 | ADA 2022 | News | Article

    Women most often have psychosocial consequences of hypoglycemia

    “Social constructs on stress management may explain the observed gender differences and suggest taking a gender-based differential approach when addressing hypoglycemia,” conclude the researchers. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  17. 06-06-2022 | ADA 2022 | News | Article

    Psychosocial factors predict poor medication adherence in young people with type 2 diabetes

    It’s not enough to tell them to remember to take their medications.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  18. 06-05-2022 | ADA 2022 | News | Article

    Vitamin B12 monitoring rare despite metformin prescription

    The monitoring rate was only slightly higher among people with neuropathy, at 10.1% and 3.7% for those seen in primary care and endocrinology, respectively. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  19. 06-05-2022 | ADA 2022 | News | Article

    Almost any liver fat may be abnormal

    “Our findings suggest that the presence of any liver fat may be abnormal,” concluded Le, adding that an MRS cutoff of around 2% may be optimal for defining non-alcoholic fatty liver disease. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

  20. 06-05-2022 | ADA 2022 | News | Article

    Success of Omnipod 5 closed-loop system in preschoolers continues at 1 year

    “These long-term data provide evidence of the durability of the Omnipod 5 for safely and effectively improving outcomes in very young kids with type 1 diabetes and also alleviating the burden of daily diabetes management,” concluded DeSalvo. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.